Australija - engleski - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - bimatoprost, quantity: 300 microgram/ml - eye drops, solution - excipient ingredients: hydrochloric acid; benzalkonium chloride; sodium hydroxide; purified water; citric acid monohydrate; dibasic sodium phosphate heptahydrate; sodium chloride - for the reduction of elevated intraocular pressure, or open angle glaucoma, as first line therapy or monotherapy or as adjunctive therapy to topical beta-blockers.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - bimatoprost, quantity: 0.3 mg/ml - eye drops - excipient ingredients: sodium hydroxide; sodium chloride; hydrochloric acid; water for injections; benzalkonium chloride; citric acid monohydrate; dibasic sodium phosphate heptahydrate - for the reduction of elevated intraocular pressure, or open angle glaucoma, as first line therapy or monotherapy or as adjunctive therapy to topical beta- blockers.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - bimatoprost, quantity: 300 microgram/ml - eye drops, solution - excipient ingredients: sodium chloride; citric acid monohydrate; hydrochloric acid; water for injections; dibasic sodium phosphate heptahydrate; sodium hydroxide - for the reduction of elevated intraocular pressure, or open angle glaucoma, as first line therapy or monotherapy or as adjunctive therapy to topical beta-blockers

Malezija - engleski - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

abbvie sdn bhd - bimatoprost -

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - bimatoprost 0.3 mg/ml - eye drops, solution - 0.3 mg/ml - active: bimatoprost 0.3 mg/ml excipient: citric acid monohydrate dibasic sodium phosphate heptahydrate hydrochloric acid sodium chloride sodium hydroxide water for injection - indicated as monotherapy for the reduction of elevated intraocular pressure (iop) in patients with chronic glaucoma or ocular hypertension; or as adjunctive therapy in patients not adequately controlled on other agents.